Local Verification and Assignment of Mean Normal Prothrombin Time and International Sensitivity Index Values across Various Instruments: Recent Experience and Outcome from North America

Abstract

Warfarin dosing relies on accurate measurements of international normalized ratio (INR), which is calculated from the prothrombin time (PT), International Sensitivity Index international sensitivity index (ISI) of the thromboplastin, and the geometric mean of normal PT (MNPT). However, ISI assignments of certain reagent/instrument combinations are frequently unavailable, especially when the reagent and instrument are not from the same manufacturer. The effort to be in compliance with widely endorsed Clinical and Laboratory Standards Institute (CLSI) guidelines by locally verifying or assigning an ISI to an unsupported reagent/instrument combination is further hindered by the lack of US Food and Drug Administration (FDA)–approved certified plasmas designated for a particular reagent/instrument combination. The objectives of the study include development of a process to verify/assign ISI and MNPT of a single thromboplastin reagent from one manufacturer across multiple instruments including several from another manufacturer and across several campuses of a single institution, the Mayo Clinic. In this study, RecombiPlasTin 2G (R2G), was evaluated on the ACL TOP 700 (IL), STA-R Evolution, STA Compact, and STA Satellite. Random normal donor samples (n = 25) were used to verify/assign MNPT. A subset of the normal donors (n = 8) and 13 warfarin pools (INR range: 1.3–3.9), created from stable warfarin patient plasma, were used for ISI verification/assignment. The manufacturer's assigned ISI was first verified on the ACL TOP 700 (reference method), then assigned on three unsupported instruments using orthogonal regression analysis. The MNPT and manufacturer assigned ISI (11.0, 0.95) were verified on the ACL TOP 700 and subsequently assigned on the STA-R Evolution (11.6, 1.04); STA Compact (11.5, 1.02); and STA Satellite (10.9, 0.99). Linear correlations of the INR results from all the four instruments demonstrated an r ² > 0.99. This process provides a reproducible approach to assigning ISIs on unsupported reagent/instrument combinations. Our data also confirm that ISIs of the same PT reagent differ significantly on different instruments, thus confirming the requirement for evaluations and validation of ISIs for different reagent/instrument combinations.

Keywords

international normalized ratio - prothrombin time - international sensitivity index - MNPT - standardization

• References

• 1 WHO Expert Committee on Biological Standardization. Thirty-third report–requirements for thromboplastins and plasma used to control oral anticoagulant therapy. Annex 3; WHO Technical Report Series No. 687. Geneva, Switzerland: World Health Organization; 1983: 81-105
• 2 Cunningham MT, Praestgaard J, Styer PE , et al. A method for proficiency testing of small peer groups in the College of American Pathologists Coagulation Surveys. Arch Pathol Lab Med 1999; 123 (3) 199-205
• 3 Clinical and Laboratory Standards Institute. Procedures for validation of INR and local calibration of PT/INR systems; Approved Guideline. CLSI document H54-A [ISBN 1-56238-580-1]. Wayne, PA: Clinical and Laboratory Standards Institute; 2005
• 4 Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID. Emerging technologies and quality assurance: the United Kingdom National External Quality Assessment Scheme perspective. Semin Thromb Hemost 2007; 33 (3) 243-249
• 5 Cunningham MT, Brandt JT, Chandler WL , et al. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost 2007; 33 (3) 250-258
• 6 Favaloro EJ, McVicker W, Hamdam S, Hocker N. Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?. Clin Chem Lab Med 2010; 48 (8) 1079-1090
• 7 van Rijn JL, Schmidt NA, Rutten WP. Correction of instrument- and reagent-based differences in determination of the International Normalized Ratio (INR) for monitoring anticoagulant therapy. Clin Chem 1989; 35 (5) 840-843
• 8 Hirsh J, Poller L. The international normalized ratio. A guide to understanding and correcting its problems. Arch Intern Med 1994; 154 (3) 282-288
• 9 Favaloro EJ, Adcock DM. Standardization of the INR: how good is your laboratory's INR and can it be improved?. Semin Thromb Hemost 2008; 34 (7) 593-603
• 10 Adcock DM, Duff S. Enhanced standardization of the International Normalized Ratio through the use of plasma calibrants: a concise review. Blood Coagul Fibrinolysis 2000; 11 (7) 583-590
• 11 Clinical and Laboratory Standards Institute. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. 5th ed. CLSI document H21-A5 [ISBN 1-56238-657-3]. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
• 12 Favaloro EJ, Hamdam S, McDonald J, McVicker W, Ule V. Time to think outside the box? Prothrombin time, international normalised ratio, international sensitivity index, mean normal prothrombin time and measurement of uncertainty: a novel approach to standardisation. Pathology 2008; 40 (3) 277-287
• 13 Poller L, van den Besselaar AM, Jespersen J, Tripodi A, Houghton D. A comparison of linear and orthogonal regression analysis for local INR determination in ECAA coagulometer studies. European Concerted Action on Anticoagulation. Br J Haematol 1998; 102 (4) 910-917
• 14 Poller L. International Normalized Ratios (INR): the first 20 years. J Thromb Haemost 2004; 2 (6) 849-860
• 15 WHO Expert Committee on Biological Standardization. Annex 3–Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Technical Report Series No. 889. Geneva, Switzerland: World Health Organization; 1999: 64-93
• 16 Brien WF, Baskerville JC, Taberner DA, Crawford L. Calculation vs calibration curve for INR determination. Results of an interlaboratory proficiency scheme. Am J Clin Pathol 1999; 111 (2) 193-201
• 17 Adcock DM, Johnston M. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study. Thromb Haemost 2002; 87 (1) 74-79
• 18 Favaloro EJ, Plebani M, Lippi G. Regulation in hemostasis and thrombosis: part I-in vitro diagnostics. Semin Thromb Hemost 2013; 39 (3) 235-249
• 19 van den Besselaar AM, Witteveen E, van der Meer FJ. Long-term stability of frozen pooled plasmas stored at −70°C, −40°C, and −20°C for prothrombin time and International Normalized Ratio (INR) assessment. Thromb Res 2013; 131 (4) 349-351